Charm Therapeuticshttps://charmtx.com/

Your landing page’s weakest score is CTA.

How Charm Therapeutics ranks

  1. 1.Charm Therapeutics57
  2. 2.Micropep Technologies56
  3. 3.Insilico Medicine54
  4. 4.Iambic Therapeutics52
  5. 5.AgPlenus49
  6. 6.Bindwell28
Fix CTA
57Growth scoreupdated

category scores

CTA44Trust52
category scoresShowHide
CTA44Trust52

CTA

44Poor

Copy, size, verb, cost-feel — does the primary CTA earn the click?

Discover
Charm Therapeutics
Micropep Technologies

Problems

  • scroll cue, not a real CTA
  • tiny footprint vs headline
  • no destination or payoff named
  • no button anywhere in hero

Trust

52Fair

Proof that the product is real, competent, and safe to try.

Charm Therapeutics
Insilico Medicine
Trust read
Charm TherapeuticsHeadline "Addressing resistance in AML with a best-in-class menin inhibitor" naming a specific target and indication
BindwellNo visible trust signal identified.
AgPlenus"Our Innovation" list detailing the platform: "Scanning billions of compounds", "De novo design of small molecules"
Insilico MedicinePipeline table rows showing "Out-licensed to Exelixis" and "Out-licensed to Menarini" with Phase I–III progress bars and
Micropep TechnologiesNo visible trust signal identified.
Iambic TherapeuticsNo visible trust signal identified.

Mobile web

58Fair

The phone experience as a first-class citizen.

Charm Therapeutics mobile capture for Mobile web

What works

What to improve

Information hierarchy

64Fair

Does the design help or inhibit what the page is trying to say?

Charm Therapeutics desktop capture for Information hierarchy

What works

What to improve

Value props

68Fair

Title, subtitle, hero — do they sell the product's true value?

Charm Therapeutics’s headlineAddressing resistance in AML with a best-in-class menin inhibitor

Working

Could improve